Underreporting of health-related quality of life in trials of matched targeted therapies for advanced or metastatic cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback